Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
Annual PBM report shows increases in overall migraine meds use by nearly 9%, while opioids drop by almost 8%SAN DIEGO – April 30,
Bill review is complex — but the right approach can unlock major savings. Learn how to streamline the process and boost efficiency.
SAN DIEGO, Calif.—Mitchell, a leader in the development of innovative auto physical damage technology solutions, today announced t